3Germing U,Gattermann N, Strupp C, et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes:a retrospectiove analysis of 1600 patients. Leuk Res,2000,24(12) :983 -992.
5Germing U,Gattermann N,Strupp C,et al.Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes:a retrospectiove analysis of 1600 patients[J].Leuk Res,2000,24(12):983-992.
7Germing U, Stmpp C, Giagounidis A, et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the DUsseldorf Registry on myelodysplastic syndromes. Leuk Res, 2012,36 : 727-734.
8Su T, Zhang PH, Xu ZF, et al. Analysis of clinical features and prog- nosis of primary myelodysplastic syndromes with mylofibrosis patients. Zhonghua Xue Ye Xue Za Zhi, 2012,33 : 378-382.
9张之南.血液病诊断及疗效标准.第2版.天津:天津科学技术出版社.1995.
10Houwerzijl EJ, Blom NR, van der Want JJ, et al. Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocy- topenic purpura is in part due to different forms of cell death. Leukemia, 2006,20 : 1937-1942.
